Grapsa E
Renal Unit,Alexandra Hospital, Athens, Greece.
Hippokratia. 2011 Jan;15(Suppl 1):13-5.
Peritoneal dialysis is the most important home dialysis treatment for end stage renal diseases and needs personal involvement, and support from the family . Peritoneal dialysis presented a number of discouraging technical problems and led to the belief that PD was not an appropriate renal replacement therapy, for patients with end stage renal disease. Despite the improvement of the method its rate remain low (11%) worldwide. The factors affecting the choice of PD are multiple and explain the disparity in the use of peritoneal dialysis in different countries and different parts of the same country. Dialysis costs and reimbursement structures are significant in decisions about the rates and modalities of renal replacement therapy. Late referral and the health care system seems to be very important factors that influence the dialysis modality choice. After the initiation of peritoneal dialysis we can see other factors that influence the survival of the method. The rate of peritonitis and the peritoneum function seems to be important issues.
腹膜透析是终末期肾病最重要的家庭透析治疗方式，需要患者个人参与以及家人的支持。腹膜透析存在一些令人沮丧的技术问题，这使得人们认为对于终末期肾病患者而言，腹膜透析并非合适的肾脏替代疗法。尽管该方法有所改进，但其在全球的使用率仍然很低（11%）。影响选择腹膜透析的因素众多，这也解释了不同国家以及同一国家不同地区腹膜透析使用情况的差异。透析费用和报销结构在肾脏替代治疗的速率和方式决策中具有重要意义。转诊延迟和医疗保健系统似乎是影响透析方式选择的非常重要的因素。在开始腹膜透析后，我们可以看到其他影响该治疗方式存活情况的因素。腹膜炎发生率和腹膜功能似乎是重要问题。
